Conjugated linoleic acid suppresses the secretion of atherogenic lipoproteins from human HepG2 liver cells

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 3, 2005, Pages 269-274

  Pal, Sebely ^a   Takechi, Ryusuke ^b   Ho, Suleen S ^a  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF HYOGO   (Japan)

Author keywords

Apolipoprotein B100 (apoB100); Atherosclerosis; Cholesterol; Conjugated linoleic acid; HepG2 liver cells; Lipoprotein

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; CONJUGATED LINOLEIC ACID; FATTY ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OMEGA 6 FATTY ACID; PALMITIC ACID; SATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; HUMAN; HUMAN CELL; INCUBATION TIME; LIVER CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; RISK REDUCTION; WESTERN BLOTTING;

APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CELL LINE; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL ESTERS; HEPATOCYTES; HUMANS; LINOLEIC ACIDS; LINOLEIC ACIDS, CONJUGATED; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; PALMITIC ACID;

EID: 17044438298     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.045     Document Type: Article

References (28)

1. Mangiapane EH, Salter AM. Diet, lipoproteins and coronary heart disease: a biochemical perspective. Nottingham: Nottingham University Press, 1999.
2. Mamo JC, Proctor SD, Smith D. Retention of chylomicron remnants by arterial tissue: importance of an efficient clearance mechanism from plasma. Atherosclerosis 1998;141:S61-9.
3. Porth CM, Kunert MP. Pathophysiology: concepts of altered health states, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2002.
4. Berry EM, Eisenberg S, Horatz D, Friedlander Y, Norman Y, Kaufmann NA, et al. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins - the Jerusalem Nutritional Study: high MUFAs vs. high PUFAs. Am J Clin Nutr 1991;53:899-907.
5. Dietschy JM. Dietary fatty acids and the regulation of plasma low density lipoprotein cholesterol concentrations. J Nutr 1998;128:444S-8S.
6. Chait A, Onitiri A, Nicoll A, Rabaua E, Davis H, Lewis B. Reduction of serum triacylglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition. Atherosclerosis 1974; 20:347-64.
7. Cortese C, Levy Y, Janus ED, Turner PR, Roa SN, Miller NE, et al. Mode of action of lipid lowering diets in man: studies of apoprotein B kinetics in relation to fat consumption and dietary fatty acid consumption. Eur J Clin Invest 1983;13:79-85.
8. Noone EJ, Roche HM, Nugent AP, Gibney MJ. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 2002;88:243-51.
9. Yotsumoto H, Hara E, Naka S, Adlof RO, Emken EA, Yanagita T. 10-Trans, 12-cis-linoleic acid reduces apolipoprotein B secretion in HepG2 cells. Food Res Int 1999; 31:403-9.
10. Pal S, Thomson AM, Bottema CD, Roach PD. Polyunsaturated fatty acids downregulate the low density lipoprotein receptor of human HepG2 cells. J Nutr Biochem 2002;13:55-63.
11. Folch J, Lees M, Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
12. Zilversmit DB, Shea TM. Quantitation of apoB-48 and apoB-100 by gel scanning or radio-iodination. J Lipid Res 1989;30:1639-46.
13. Pal S, Ho N, Santos C, Dubois P, Mamo J, Croft K, et al. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of apoB100 from human HepG2 cells. J Nutr 2003;133:700-6.
14. Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med 2000;223:8-13.
15. Benito P, Nelson GJ, Kelley DS, Bartolini G, Schmidt PC, Simon V. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 2001;36:229-36.
16. Alasnier C, Berdeaux O, Chardigny JM, Sébédio JL. Fatty acid composition and conjugated linoleic acid content of different tissues in rats fed individual conjugated linoleic acid isomers given as triacylglycerols. J Nutr Biochem 2002;13:337-45.
17. Banni S, Carta G, Angioni E, Murru E, Scanu P, Melis MP, et al. Distribution of conjugated linoleic acid and metabolites in different lipid fractions in the rat liver. J Lipid Res 2001;42:1056-61.
18. Sugano M, Tsujita A, Yamasaki M, Yamada K, Ikeda I, Kritchevsky D. Lymphatic recovery, tissue distribution, and metabolic effects of conjugated linoleic acid in rats. J Nutr Biochem 1997;8:38-47.
19. Ip C, Chin SF, Scimeca JA, Pariza MW. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res 1991;51:6118-24.
20. Mougious V, Matsakas A, Petridou A, Ring S, Sagredos A, Melissopoulou A, et al. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J Nutr Biochem 2001;12:585-94.
21. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000;130:2943-48.
22. White DA, Bennett AJ, Billett MA, Salter AM. The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein. Br J Nutr 1998;80:219-29.
23. Arrol S, Mackness MI, Durrington PN. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2). Atherosclerosis 2000;150:255-64.
24. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001;40:439-52.
25. Yu-Poth S, Yin D, Zhao G, Kris-Etherton PM, Etherton TD. Conjugated linoleic acid upregulates LDL receptor gene expression in HepG2 cells. J Nutr 2004;134:6-71.
26. Forster LF, Stewart G, Bedford D, Stewart JP, Rogers E, Shepherd J, et al. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates. Atherosclerosis 2002; 164:129-45.
27. Scharnagl H, Schinker R, Gierens H, Nauck M, Wieland H, März W. Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells. Biochem Pharmacol 2001; 62:1545-55.
28. Thrift RN, Forte TM, Cahoon BE, Shore VG. Characterization of lipoproteins produced by the human liver cell line, HepG2, under defined conditions. J Lipid Res 1986;27:236-50.